Cargando…
Artificial intelligence-based decision support model for new drug development planning
New drug development guarantees a very high return on success, but the success rate is extremely low. Pharmaceutical companies have attempted to use various strategies to increase the success rate of drug development, but this goal has been difficult to achieve. In this study, we developed a model t...
Autores principales: | Jung, Ye Lim, Yoo, Hyoung Sun, Hwang, JeeNa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902892/ https://www.ncbi.nlm.nih.gov/pubmed/35283560 http://dx.doi.org/10.1016/j.eswa.2022.116825 |
Ejemplares similares
-
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study
por: Jung, Ye Lim, et al.
Publicado: (2020) -
Artificial intelligence for clinical decision support in neurology
por: Pedersen, Mangor, et al.
Publicado: (2020) -
Artificial Intelligence for Clinical Decision Support in Sepsis
por: Wu, Miao, et al.
Publicado: (2021) -
Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality
por: Sher, David J., et al.
Publicado: (2021) -
Artificial intelligence to support clinical decision-making processes
por: Garcia-Vidal, Carolina, et al.
Publicado: (2019)